Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

Fig. 2

Forest plot comparing the adverse clinical outcomes between TAPT and DAPT in T2DM patients after intracoronary stenting. Adverse clinical outcomes have decreased with the use of this TAPT during a follow up period of 9 to 12 months after coronary stenting

Back to article page